Elite Pharmaceuticals Inc (ELTP) stock
ELTPOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 14/30
$0.25−0.00 (-1.37%)
Close on Oct 19, 2026Market cap $281.77MP/E 5.0Yield –
Elite Pharmaceuticals EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Elite Pharmaceuticals's EV/EBITDA was 6.4× on Oct 19, 2026, against 16.5× a year earlier. Over the last 5 years it ranged from 2.0× to 38.9×, with a median of 10.3×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 6.4× | −5.1 |
| 2025 | Dec 31, 2025 | 11.5× | −24.4 |
| 2024 | Dec 31, 2024 | 35.9× | +15.1 |
| 2023 | Dec 29, 2023 | 20.8× | +18.8 |
| 2022 | Dec 30, 2022 | 2.0× | −5.2 |
| 2021 | Dec 31, 2021 | 7.2× | −9.1 |
| 2020 | Dec 31, 2020 | 16.3× | – |
See a number that looks wrong?